The potential for improved outcomes in the prevention and therapy of diabetic kidney disease through 'stacking' of drugs from different classes.

导出 LinkOut

翻译打印收藏纠错

作者： David S H,Bell ^[1] ; Terri,Jerkins ^[2]

作者单位： University of Alabama Medical School and Southside Endocrinology, Irondale, Alabama, USA. ^[1] Midstate Endocrine Associates, Lipscomb University, Nashville, Tennessee, USA. ^[2]

关键词 DPP‐4 inhibitors GLP‐1 receptor agonists SGLT2 inhibitors blockers on the renin‐angiotensin system (RAS blockers)carvedilol mineralocorticoid receptor antagonists (MRAs)pentoxifylline statins

主题词人类(Humans);糖尿病肾病(Diabetic Nephropathies);血管紧张素转换酶抑制药(Angiotensin-Converting Enzyme Inhibitors);药物疗法, 联合(Drug Therapy, Combination);疾病恶化(Disease Progression);肾素-血管紧张素系统(Renin-Angiotensin System);治疗结果(Treatment Outcome);血管紧张素受体拮抗剂(Angiotensin Receptor Antagonists);胰高血糖素样肽1(Glucagon-Like Peptide 1);降血糖药(Hypoglycemic Agents);糖尿病, 2型(Diabetes Mellitus, Type 2);二肽基肽酶Ⅳ抑制剂(Dipeptidyl-Peptidase IV Inhibitors)

DOI 10.1111/dom.15559

PMID 38516874

发布时间 2024-05-22

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Diabetes, obesity & metabolism

2024年26卷6期

2046-2053页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

The potential for improved outcomes in the prevention and therapy of diabetic kidney disease through 'stacking' of drugs from different classes.

Diabetes, obesity & metabolism

相似文献

Diabetes, obesity & metabolism

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

The potential for improved outcomes in the prevention and therapy of diabetic kidney disease through 'stacking' of drugs from different classes.

Diabetes, obesity & metabolism

相似文献

Diabetes, obesity & metabolism

相关期刊

检索历史清除